NEWS

Nuestro últimos avances en la curcumina del tipo profármaco soluble en agua (CMG), será presentado en la conferencia GAP 2018 (Karolinska Institute in Sweden): Kanai, M., Imaizumi, A., Kakeya, H. “Development of a water-soluble curcumin monoglucronide (CMG) as a novel anticancer prodrug targeting KRAS-NF-kappa B signaling pathway”, GAP (Global Academic Programs) conference, Stockholm, Sweden, May, 2018.